Urology and surgical company Imagyn Medical Technologies of Newport Beach, CA, filed for Chapter 11 bankruptcy protection last week in an effort to preempt a group of creditors that has been trying to force the company into involuntary bankruptcy.
Urology and surgical company Imagyn Medical Technologies of Newport Beach, CA, filed for Chapter 11 bankruptcy protection last week in an effort to preempt a group of creditors that has been trying to force the company into involuntary bankruptcy. Imagyn executives said they plan to develop a reorganization plan for the company and solicit new financing to get the firm back on its feet. While Imagyn doesnt participate directly in the radiology segment, the company does have OEM relationships with several medical imaging companies, including International Isotopes and Fischer Imaging.
FDA Clears Enhanced MRI-Guided Laser Ablation System
June 5th 2025An alternative to an open neurosurgical approach, the Visualase V2 MRI-Guided Laser Ablation System reportedly utilizes laser interstitial thermal therapy (LITT) for targeted soft tissue ablation in patients with brain tumors and focal epilepsy.
Can Abbreviated MRI Have an Impact in Differentiating Intraductal Papilloma and Ductal Secretion?
June 3rd 2025For patients with inconclusive ultrasound results, abbreviated breast MRI offers comparable detection of intraductal papilloma as a full breast MRI protocol at significantly reduced times for scan acquisition and interpretation, according to a new study.
Can AI Assessment of PET Imaging Predict Treatment Outcomes for Patients with Lymphoma?
June 2nd 2025The use of adjunctive AI software with pre-treatment PET imaging demonstrated over a fourfold higher likelihood of predicting progression-free survival (PFS) in patients being treated for lymphoma, according to a new meta-analysis.